Tower Bridge Advisors Pfizer Inc Transaction History

Tower Bridge Advisors

$895 Billion
Q1 2025

A detailed history of Tower Bridge Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Tower Bridge Advisors holds 63,988 shares of PFE stock, worth $1.48 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

63,988

Previous 64,997 1.55%

Holding current value

$1.48 Million

Previous $1.72 Billion 5.97%

% of portfolio

0.18%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$25.01 - $27.13 $25,235 - $27,374	-1,009 Reduced 1.55%	63,988 $1.62 Billion
Q4 2024 Feb 05, 2025	BUY	$24.8 - $30.19 $32,140 - $39,126	1,296 Added 2.03%	64,997 $1.72 Billion
Q3 2024 Nov 06, 2024	SELL	$27.7 - $31.39 $52,325 - $59,295	-1,889 Reduced 2.88%	63,701 $1.84 Billion
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $39,481 - $46,264	1,563 Added 2.44%	65,590 $1.84 Billion
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $62,136 - $71,352	-2,400 Reduced 3.61%	64,027 $1.78 Billion
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $77,083 - $100,123	-2,950 Reduced 4.25%	66,427 $1.91 Billion
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $121,909 - $142,500	3,799 Added 5.79%	69,377 $2.3 Billion
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $4.1 Million - $4.75 Million	-113,601 Reduced 63.4%	65,578 $2.41 Billion
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $15,362 - $19,999	-390 Reduced 0.22%	179,179 $7.31 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $109,356 - $133,496	-2,499 Reduced 1.37%	179,569 $7.86 Billion
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $254,798 - $302,110	-5,476 Reduced 2.92%	182,068 $9.55 Billion
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $101,931 - $126,305	-2,228 Reduced 1.17%	187,544 $9.71 Billion
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $33,056 - $49,000	-800 Reduced 0.42%	189,772 $11.2 Billion
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $20,802 - $26,722	-530 Reduced 0.28%	190,572 $8.2 Billion
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $189,568 - $214,749	5,279 Added 2.84%	191,102 $7.48 Billion
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $341,363 - $384,989	-10,193 Reduced 5.2%	185,823 $6.73 Billion
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $911,622 - $1.16 Million	27,237 Added 16.14%	196,016 $7.22 Billion
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $35,083 - $41,161	-1,105 Reduced 0.65%	168,779 $6.19 Billion
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $39,680 - $56,694	-1,468 Reduced 0.86%	169,884 $5.55 Billion
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $707,681 - $803,127	-21,497 Reduced 11.15%	171,352 $6.71 Billion
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $46,298 - $60,035	-1,425 Reduced 0.73%	192,849 $7.15 Billion
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $1,146 - $1,287	31 Added 0.02%	194,274 $8.42 Billion
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $187,650 - $206,164	5,004 Added 2.64%	194,243 $8.25 Billion
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $419,515 - $478,293	-10,905 Reduced 5.45%	189,239 $8.26 Billion
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $33,952 - $41,182	-985 Reduced 0.49%	200,144 $8.82 Billion
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $25,988 - $27,706	-788 Reduced 0.39%	201,129 $7.3 Billion
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $183,131 - $212,457	-5,739 Reduced 2.76%	201,917 $7.17 Billion
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $4,456 - $4,728	134 Added 0.06%	207,656 $7.52 Billion
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $6.43 Million - $7.09 Million	207,522	207,522 $7.41 Billion

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $130B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Pfizer Inc Transaction History